These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17075997)

  • 1. [Resistance to protease inhibitors: the burden of mutations].
    Marcelin AG
    Med Mal Infect; 2006 Jul; 36 Suppl 2():S198-205. PubMed ID: 17075997
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
    Krogstad PA
    J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatment-naive patients.
    Metzner KJ; Allers K; Rauch P; Harrer T
    AIDS; 2007 Mar; 21(6):703-11. PubMed ID: 17413691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.
    Cozzi-Lepri A; Phillips AN; Ruiz L; Clotet B; Loveday C; Kjaer J; Mens H; Clumeck N; Viksna L; Antunes F; Machala L; Lundgren JD;
    AIDS; 2007 Mar; 21(6):721-32. PubMed ID: 17413693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
    Derache A; Traore O; Koita V; Sylla A; Tubiana R; Simon A; Canestri A; Carcelain G; Katlama C; Calvez V; Cisse M; Marcelin AG
    Antivir Ther; 2007; 12(1):123-9. PubMed ID: 17503757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2004 antiretroviral drug guide.
    IAPAC Mon; 2004 Oct; 10 Suppl 1():8-35. PubMed ID: 15641182
    [No Abstract]   [Full Text] [Related]  

  • 8. First once-daily protease inhibitor.
    FDA Consum; 2003; 37(5):4. PubMed ID: 14666889
    [No Abstract]   [Full Text] [Related]  

  • 9. The risks and incidence of K65R and L74V mutations and subsequent virologic responses.
    Waters L; Nelson M; Mandalia S; Bower M; Powles T; Gazzard B; Stebbing J
    Clin Infect Dis; 2008 Jan; 46(1):96-100. PubMed ID: 18171220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV-1 protease inhibitors: cell metabolism and drug resistance (review)].
    Bobkova MR
    Ter Arkh; 2008; 80(10):77-80. PubMed ID: 19105421
    [No Abstract]   [Full Text] [Related]  

  • 11. [Is HIV more and more resistant?].
    Chaix ML; Delaugerre C; Viard JP
    Rev Prat; 2004 Mar; 54(5):471-4. PubMed ID: 15176501
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects.
    Vicenti I; Razzolini F; Saladini F; Romano L; Zazzi M
    Clin Infect Dis; 2007 Jun; 44(12):1657-61. PubMed ID: 17516412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antiretroviral agents and the complexity of treatment practices.
    Smith D
    J HIV Ther; 2008 Jun; 13(2):25-6. PubMed ID: 18953270
    [No Abstract]   [Full Text] [Related]  

  • 14. [HIV-1 drug resistance in French infected-children: from newborn to adolescent].
    Delaugerre C; Chaix ML; Warszawski J; Rouzioux C; Blanche S
    Arch Pediatr; 2007 Mar; 14(3):298-302. PubMed ID: 17287114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006.
    Maphalala G; Okello V; Mndzebele S; Gwebu P; Mulima N; Dlamini S; Nhlabatsi B; Ginindza T; Ghebrenegus Y; Ntilivamunda A; Mwanyumba F; Ledwaba J; Pillay V; Bennett DE
    Antivir Ther; 2008; 13 Suppl 2():95-100. PubMed ID: 18575197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical data released on PI.
    AIDS Patient Care STDS; 2003 Sep; 17(9):483-4. PubMed ID: 14596252
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutation rate in hepatitis C virus NS3 protease is not influenced by HIV-1 protease inhibitor therapy.
    Halfon P; Bourlière M; Khiri H; Pénaranda G; Martineau A; Oulès V; Courcambeck J; Philibert P
    AIDS; 2008 Aug; 22(13):1694-6. PubMed ID: 18670239
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV drug resistance transmission threshold survey in Bangkok, Thailand.
    Sirivichayakul S; Phanuphak P; Pankam T; O-Charoen R; Sutherland D; Ruxrungtham K
    Antivir Ther; 2008; 13 Suppl 2():109-13. PubMed ID: 18575199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance to anti-retroviral therapy in Chilean patients with HIV-1 from 2002 to 2005].
    Afani S A; Orellana R L; Duarte J P; Acevedo M W; Morales B O; Wolff R M; Vásquez P; Beltrán C
    Rev Med Chil; 2007 Oct; 135(10):1237-44. PubMed ID: 18180829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to Waters et al. "Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia ...".
    Kan VL; Gale HB; Shinol RC
    AIDS; 2006 Oct; 20(15):1991-2. PubMed ID: 16988529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.